Clinical Trial Update: Intravenous Enhancin[Co-amoxiclav] Versus Postoperative Enhancin in Prevention of Postadenotonsillectomy Morbidity. [NA]

View source ↗

Summary

A completed trial compared intravenous Co-amoxiclav (Enhancin) versus postoperative Enhancin for prevention of morbidity after adenotonsillectomy in children un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenotonsillar Hypertrophy

Drugs mentioned

• Enhancin (intravenous) (amoxicillin/clavulanic acid)
• Enhancin (postoperative) (amoxicillin/clavulanic acid)

Snippet

Sponsor: University of Nairobi | Conditions: Adenotonsillar Hypertrophy,Under 12 Years. | NA | Status: COMPLETED